About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Recreational Drug Methamphetamine Overdose Deaths Rise Sharply

by Colleen Fleiss on January 21, 2021 at 11:12 PM
Font : A-A+

Recreational Drug Methamphetamine Overdose Deaths Rise Sharply

In the United States, methamphetamine overdose deaths surged in eight years, according to a study published today in JAMA Psychiatry.

The research was conducted at the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.

Advertisement


From 2011-2018, methamphetamine deaths more than quadrupled among non-Hispanic American Indians and Alaska Natives. The study findings highlight the urgent need to develop culturally tailored, gender-specific prevention and treatment strategies for methamphetamine use disorder.

Long-term decreased access to education, high poverty rates, and discrimination in health services delivery are among factors that contribute to health disparities for American Indians and Alaska Natives.
Advertisement

"While much attention is focused on the opioid crisis, a methamphetamine crisis has been quietly, but actively, gaining steam--particularly among American Indians and Alaska Natives, who are disproportionately affected by a number of health conditions," said Nora D. Volkow, M.D., NIDA director and a senior author of the study.

Leveraging traditions such as talking circles may offer a unique and culturally resonant way to prevent drug use among young people. Non-Hispanic American Indian and Alaska Native women had higher rates than non-Hispanic Black, Asian, or Hispanic men during 2012-2018.

Methamphetamine Use Disorder Treatment

Methamphetamine use is associated with a range of serious health risks, including overdose deaths. There are currently no FDA-approved medications for treating methamphetamine use disorder or reversing overdoses.

Behavioral therapies such as contingency management therapy can effectively reduce the harms associated with the use of methamphetamine.

A recent clinical trial reported significant therapeutic benefits with naltrexone with bupropion in patients with methamphetamine use disorders.

NIDA investigators led by Beth Han, M.D., Ph.D., M.P.H., obtained data used in the analysis from the 2011-2018 Multiple Cause-of-Death records from the Centers for Disease Control and Prevention's National Vital Statistics System, the nation's most complete database of births and deaths.

Most people who use methamphetamine are between 25 and 54 years old. Deaths involving methamphetamines rose from 1.8 to 10.1 per 100,000 men, and from 0.8 to 4.5 per 100,000 women. The figures represent a more than five-fold increase from 2011 to 2018.

"Identifying populations that have a higher rate of methamphetamine overdose is a crucial step toward curbing the underlying methamphetamine crisis," said Dr. Han.

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Drinking This Popular Beverage May Drop Dementia Risk
Worst Mistakes Parents Make When Talking to Kids
World Lupus Day 2022: Standing Along With the Lupus Patients
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity Bereavement Drugs Banned in India Recreational Drugs are not Completely Safe 

Most Popular on Medindia

Sanatogen Indian Medical Journals The Essence of Yoga Noscaphene (Noscapine) Diaphragmatic Hernia Hearing Loss Calculator Drug Side Effects Calculator A-Z Drug Brands in India Turmeric Powder - Health Benefits, Uses & Side Effects Daily Calorie Requirements

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use